The downgrade is a result of Houston Healthcare’s operational challenges in fiscal year 2017, including a lower than average operating performance, declining patient volume and struggle to recruit physicians. Moody’s also acknowledged Houston Healthcare’s strong liquidity metrics.
The outlook was revised to negative from stable, reflecting the pressure Houston Healthcare’s performance faces until it can stabilize patient volumes and restore financial performance to average levels.
More articles on healthcare finance:
10 grants, donations to healthcare organizations in November
10 recent hospital, health system outlook and credit rating actions
Jackson Health System posts a profit for 6th consecutive year
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
